active pharmaceutical ingredients
ELECTROSPRAY IONIZATION MASS SPECTROMETRY FRAGMENTATION PATHWAYS OF SALTS OF SOME 1,2,4 TRIAZOLYLTHIOACETATE ACIDS, THE ACTIVE PHARMACEUTICAL INGREDIENTS
... of active pharmaceutical ingredients, derivatives, 1,2,3-triazole-ylthio-acetate acids in case of two different voltages during fragmentation, ...
10
PRESENCE OF ORGANIC IMPURITIES INTO ACTIVE PHARMACEUTICAL INGREDIENTS: A REVIEW
... of pharmaceutical impurities in active pharmaceutical ingredients and control of these are a major issue for all pharmaceutical ...of active pharmaceutical ...
31
Self-assembled sorbitol-derived supramolecular hydrogels for the controlled encapsulation and release of active pharmaceutical ingredients
... Active pharmaceutical ingredients (APIs) can be formulated into LMWGs using one of two strategies: (a) covalent conjugation and (b) physical ...
6
Co-crystals: A novel approach to modify physicochemical properties of active pharmaceutical ingredients
... the active pharmaceutical ingredients and the bulk material properties can be modified, whilst maintaining the intrinsic activity of the drug ...of active pharmaceutical ...
12
“GC and GC-MS Detection of Alkyl Mesylates in Active Pharmaceutical Ingredients” by N Balaji, Sayeeda Sultana, India.
... three active pharmaceutical ingredients [APIs: dolasetronmesylate (DOL), benztropinemesylate (BM), and dabigatranetexilatemesylate (DEM)] by a capillary gas chromatography method using flame ...
5
Regulatory Aspects of Cleaning and Cleaning Validation in Active Pharmaceutical Ingredients
... and active pharmaceutical ingredients (APIs) can be contaminated by other pharmaceutical products or APIs, by cleaning agents, by microorganisms or by other materials ...the ...
6
Crystal Engineering of Active Pharmaceutical Ingredients with Low Aqueous Solubility and Bioavailability
... occurring pharmaceutical derived from ...soluble active pharmaceutical ingredients to co-amorphous mixtures, solvates, co-crystals and eutectics, the solubility can be significantly ...
130
Sustainable Production of Highly Active Pharmaceutical Ingredients (HAPIs)
... Abstract- This paper deals with the sustainable and best methods that should be employed in the production of Highly Active Pharmaceutical Ingredients (HAPIs). We start with a brief introduction of ...
5
Study of technological properties of the active pharmaceutical ingredients for developing the combined medicine for neuropathy complex treatment
... of pharmaceutical development the technological properties of the initial active pharmaceutical ingredients and their combination (morphological properties of substances and their ...
5
POLYMORPHISM AND SOLUBILITY OF SELECTED ACTIVE PHARMACEUTICAL INGREDIENTS
... of active pharmaceutical ingredients (APIs) and address the solubility, stability and hydration problems using the crystal engineering ...academicians, pharmaceutical scientists and US-FDA ...
15
Development and application of high resolution solid state NMR methods for probing polymorphism of active pharmaceutical ingredients
... The work presented in this thesis has focussed on the development of solid-state NMR techniques for studying the structure of crystalline organic molecules, specifically in application to the study of active ...
170
Assessment of active pharmaceutical ingredients in drug registration procedures in Pakistan : implications for the future
... convince pharmaceutical companies through discussions, seminars, and dialogue, of the need to adopt these new requirements for drug registration, to improve patient care and the potential for drug ...the ...
14
A NOVEL RP HPLC METHOD FOR THE QUANTIFICATION OF CABOZANTINIB IN ACTIVE PHARMACEUTICAL INGREDIENTS AND PHARMACEUTICAL DOSAGE FORMS
... CONCLUSION: A simple, linear, accurate and precise HPLC method was developed and validated for the analysis of Cabozantinib in active pharmaceutical ingredient and pharmaceutical dosage form. The ...
7
Enabling precision manufacturing of active pharmaceutical ingredients : workflow for seeded cooling continuous crystallisation
... the pharmaceutical industry and regulatory agencies as a means to pro- vide a consistent supply of ...rapid pharmaceutical process development with the associated constraints of speed to market and limited ...
32
Enabling precision manufacturing of active pharmaceutical ingredients : workflow for seeded cooling continuous crystallisations
... the pharmaceutical industry and regulatory agencies as a means to pro- vide a consistent supply of ...rapid pharmaceutical process development with the associated constraints of speed to market and limited ...
32
Investigating effect of water of hydration on active pharmaceutical ingredients in a water-sensitive dosage form
... When pharmaceutical scien- tists purchase raw materials, caution for the impurity be- ing trapped in during manufacturing and purification processes must be ...
8
A NOVEL VALIDATED STABILITY INDICATING HPTLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF IRBESARTAN AND HYDROCHLOROTHIAZIDE IN ACTIVE PHARMACEUTICAL INGREDIENTS
... From the above resulting solution 8 µL of sample solution containing 1200 ng/spot of irbesartan and 100 ng/spot of hydrochlorothiazide were injected and from the peak area of irbesartan [r] ...
14
Polymorph And Salts Of Active Pharmaceutical Ingredients
... The importance of discovering all polymorphs of an active pharmaceutical ingredient cannot be overstated. The late discovery of polymorphs can lead to a delay in the time to market for a drug. Once a drug ...
6
Innovative approaches towards understanding the dissolution and growth of active pharmaceutical ingredients
... This behavior, and its comparison to the pBDD response and the behavior on a surface freshly prepared before each voltammagram discussed below, is strongly indicative of the HOPG surface[r] ...
200
“Bi-Layer Tablet Technology: A Review” by S. R. Shahi, T.B.Ingale, D.R.Magar, G.S.Karwa, India.
... of Active Pharmaceutical Ingredients (API) with predetermined drug release profile by combining layers with various release pattern or by combining slow release with immediate release ...
9